Turing CEO To Roll Back 4,000-Percent Cost Hike For AIDS Drug To ‘More Affordable’ Price

CNN Money also profiles Martin Shkreli, the controversial Turing Pharmaceuticals chief executive who has gained notoriety through his company's pricing move and subsequent defense on social media.